SEC Form 4 · accession 0001209191-15-078151
CHIMERIX INC · CMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martha J Demski
Director
Period of report
Nov 2, 2015
Accepted (ET)
Nov 3, 2015 · 5:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001117480
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 2, 2015 | M | 1,126 | $1.53 | A | 1,126 | D | |
| Common Stock | Nov 2, 2015 | S | 100 | $39.07 | D | 1,026 | D | |
| Common Stock | Nov 2, 2015 | S | 100 | $40.49 | D | 926 | D | |
| Common StockF2 | Nov 2, 2015 | S | 926 | $41.69 | D | 0 | D | |
| Common Stock | holding | — | — | — | 14,788 | I | By the Martha J. Demski Trust u/a 10/01/94 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $1.53 | Nov 2, 2015 | M | 1,126 | D | — | Jun 25, 2018 | Common Stock | 1,126 | 0 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on September 15, 2014.
- F2The range of sale prices received is $41.20 to $41.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- F3Immediately exercisable.